Medacta Group S.A.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MEDGF research report →
Companywww.medacta.com
Medacta Group SA develops, manufactures, and distributes orthopedic and neurosurgical medical devices Europe, North America, the Asia-Pacific, and internationally. It offers personalized kinematic models and 3D planning tools for use in hip, knee, shoulder, sports medicine, and spine procedures. The company was founded in 1958 and is headquartered in Castel San Pietro, Switzerland.
- CEO
- Francesco Siccardi
- IPO
- 2019
- Employees
- 1,907
- HQ
- Castel San Pietro, CH
Price Chart
Valuation
- Market Cap
- $1.67B
- P/E
- 34.23
- P/S
- 4.73
- P/B
- 7.17
- EV/EBITDA
- 18.18
- Div Yield
- 0.74%
Profitability
- Gross Margin
- 67.08%
- Op Margin
- 16.90%
- Net Margin
- 13.96%
- ROE
- 21.69%
- ROIC
- 11.90%
Growth & Income
- Revenue
- $688.06M · 16.51%
- Net Income
- $96.09M · 31.84%
- EPS
- $4.81 · 31.42%
- Op Income
- $115.62M
- FCF YoY
- 1119.01%
Performance & Tape
- 52W High
- $83.91
- 52W Low
- $83.91
- 50D MA
- $83.91
- 200D MA
- $83.91
- Beta
- 1.12
- Avg Volume
- 35
Get TickerSpark's AI analysis on MEDGF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our MEDGF Coverage
We haven't published any research on MEDGF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate MEDGF Report →